person · Reporting owner
MITTELSTAEDT ROBERT E JR
Disclosed activity across 2 companies
Sign in to followReported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (2)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
INNOVATIVE SOLUTIONS & SUPPORT INC
Report date June 14, 2022 · Filed June 15, 2022
Section 16 reporting ended · disclosed 2022-05-04. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 124,008 |
Reported balance
After 2022-06-14 transaction · row 1
1 source rowRow 1 · 2022-06-14 · Sale · Disposed 6,029 · Balance 124,008 |
LABCORP HOLDINGS INC.
Report date May 09, 2019 · Filed May 13, 2019
Section 16 reporting ended · disclosed 2019-05-13. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 15,515 |
Reported balance
After 2019-05-09 transaction · row 1
1 source rowRow 1 · 2019-05-09 · Exercise / conversion · Acquired 306 · Balance 15,515 F1: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2019-05-09 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2019-05-09 · Exercise / conversion · Disposed 306 · Balance 0 F1: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F2: The Restricted Stock Units vested fully on May 9, 2019. |
Filing footnotes · ownership attribution and instrument terms
F1: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.
F2: The Restricted Stock Units vested fully on May 9, 2019.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 14, 2022 Filed Jun 15, 2022 20:27 UTC | INNOVATIVE SOLUTIONS & SUPPORT INC ISSC · Entity 544 | SaleCommon Stock | 6,029 | $6.72 | $40,514.28 |
DisclosureSEC source: 0001104659-22-071467 · tm2218564-1_4seq1.xml · nonDerivative · entry 1 MITTELSTAEDT ROBERT E JR · CIK 0001200847 · Former Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,008 Read SEC document |
| June 07, 2022 Filed Jun 8, 2022 21:04 UTC | INNOVATIVE SOLUTIONS & SUPPORT INC ISSC · Entity 544 | SaleCommon Stock | 5,983 | $8.51 | $50,933.28 |
DisclosureSEC source: 0001104659-22-069376 · tm2217619-4_4seq1.xml · nonDerivative · entry 2 MITTELSTAEDT ROBERT E JR · CIK 0001200847 · Former Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,037 Read SEC document |
| June 06, 2022 Filed Jun 8, 2022 21:04 UTC | INNOVATIVE SOLUTIONS & SUPPORT INC ISSC · Entity 544 | SaleCommon Stock | 10,622 | $8.51 | $90,405.97 |
DisclosureSEC source: 0001104659-22-069376 · tm2217619-4_4seq1.xml · nonDerivative · entry 1 MITTELSTAEDT ROBERT E JR · CIK 0001200847 · Former Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,020 Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 20:13 UTC | INNOVATIVE SOLUTIONS & SUPPORT INC ISSC · Entity 544 | SaleCommon Stock | 6,036 | $8.95 | $54,022.20 |
DisclosureSEC source: 0001104659-22-068082 · tm2217619-3_4seq1.xml · nonDerivative · entry 1 MITTELSTAEDT ROBERT E JR · CIK 0001200847 · Former Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 146,642 Read SEC document |
| May 31, 2022 Filed Jun 2, 2022 23:32 UTC | INNOVATIVE SOLUTIONS & SUPPORT INC ISSC · Entity 544 | SaleCommon Stock | 1,330 | $8.97 | $11,934.36 |
DisclosureSEC source: 0001104659-22-067748 · tm2217619-1_4seq1.xml · nonDerivative · entry 2 MITTELSTAEDT ROBERT E JR · CIK 0001200847 · Former Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,678 Read SEC document |
| May 31, 2022 Filed Jun 2, 2022 23:32 UTC | INNOVATIVE SOLUTIONS & SUPPORT INC ISSC · Entity 544 | SaleCommon Stock | 7,732 | $8.90 | $68,814.80 |
DisclosureSEC source: 0001104659-22-067748 · tm2217619-1_4seq1.xml · nonDerivative · entry 1 MITTELSTAEDT ROBERT E JR · CIK 0001200847 · Former Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 154,008 Read SEC document |
| May 27, 2022 Filed May 31, 2022 20:15 UTC | INNOVATIVE SOLUTIONS & SUPPORT INC ISSC · Entity 544 | SaleCommon Stock | 2,268 | $8.92 | $20,228.52 |
DisclosureSEC source: 0001104659-22-066551 · tm2217198-2_4seq1.xml · nonDerivative · entry 2 MITTELSTAEDT ROBERT E JR · CIK 0001200847 · Former Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 161,740 Read SEC document |
| May 27, 2022 Filed May 31, 2022 20:15 UTC | INNOVATIVE SOLUTIONS & SUPPORT INC ISSC · Entity 544 | SaleCommon Stock | 5,264 | $8.80 | $46,323.20 |
DisclosureSEC source: 0001104659-22-066551 · tm2217198-2_4seq1.xml · nonDerivative · entry 1 MITTELSTAEDT ROBERT E JR · CIK 0001200847 · Former Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 164,008 Read SEC document |
| May 26, 2022 Filed May 27, 2022 21:27 UTC | INNOVATIVE SOLUTIONS & SUPPORT INC ISSC · Entity 544 | SaleCommon Stock | 2,864 | $8.80 | $25,203.20 |
DisclosureSEC source: 0001104659-22-066037 · tm2217198-1_4seq.xml · nonDerivative · entry 2 MITTELSTAEDT ROBERT E JR · CIK 0001200847 · Former Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 169,272 Read SEC document |
| May 25, 2022 Filed May 27, 2022 21:27 UTC | INNOVATIVE SOLUTIONS & SUPPORT INC ISSC · Entity 544 | SaleCommon Stock | 1,872 | $8.81 | $16,492.32 |
DisclosureSEC source: 0001104659-22-066037 · tm2217198-1_4seq.xml · nonDerivative · entry 1 MITTELSTAEDT ROBERT E JR · CIK 0001200847 · Former Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 172,136 Read SEC document |
| May 02, 2022 Filed May 4, 2022 21:40 UTC | INNOVATIVE SOLUTIONS & SUPPORT INC ISSC · Entity 544 | GrantCommon Stock | 2,029 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-055934 · tm2214537-1_4seq1.xml · nonDerivative · entry 1 MITTELSTAEDT ROBERT E JR · CIK 0001200847 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 174,008 F1 · security: Stock based compensation for the period January 1, 2022 through April 29, 2022. Read SEC document |
| January 03, 2022 Filed Jan 4, 2022 23:21 UTC | INNOVATIVE SOLUTIONS & SUPPORT INC ISSC · Entity 544 | GrantCommon Stock | 6,349 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-001051 · tm221460-4_4seq1.xml · nonDerivative · entry 1 MITTELSTAEDT ROBERT E JR · CIK 0001200847 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 175,068 F1 · security: Stock based compensation for the year ended December 31, 2021. Read SEC document |
| January 03, 2022 Filed Jan 7, 2022 22:00 UTC Amendment | INNOVATIVE SOLUTIONS & SUPPORT INC ISSC · Entity 544 | GrantCommon Stock | 6,349 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-002316 · tm221460-5_4aseq1.xml · nonDerivative · entry 1 MITTELSTAEDT ROBERT E JR · CIK 0001200847 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 171,978 F1 · balance_after: The original Form 4, filed on March 11, 2021, is being amended by this form 4 amendment solely to correct a typo in the amount of securities sold the original Form 4 read "175,068", whereas "171,978" was the correct amount. Read SEC document |
| March 11, 2021 Filed Mar 15, 2021 22:05 UTC | INNOVATIVE SOLUTIONS & SUPPORT INC ISSC · Entity 544 | SaleCommon Stock | 3,090 | $6.26 | $19,343.40 |
DisclosureSEC source: 0001104659-21-036435 · tm217565-10_4seq1.xml · nonDerivative · entry 1 MITTELSTAEDT ROBERT E JR · CIK 0001200847 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165,629 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.24 to $6.29, inclusive. The reporting person undertakes to provide to Innovative Solutions & Support Inc. ("ISSC"), any security holder of ISSC or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 10, 2021 Filed Mar 11, 2021 22:44 UTC | INNOVATIVE SOLUTIONS & SUPPORT INC ISSC · Entity 544 | SaleCommon Stock | 5,926 | $6.24 | $36,978.24 |
DisclosureSEC source: 0001104659-21-035109 · tm217565-9_4seq1.xml · nonDerivative · entry 1 MITTELSTAEDT ROBERT E JR · CIK 0001200847 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 166,548 Read SEC document |
| March 10, 2021 Filed Mar 15, 2021 22:06 UTC Amendment | INNOVATIVE SOLUTIONS & SUPPORT INC ISSC · Entity 544 | SaleCommon Stock | 3,755 | $6.24 | $23,431.20 |
DisclosureSEC source: 0001104659-21-036436 · tm217565-11_4aseq1.xml · nonDerivative · entry 1 MITTELSTAEDT ROBERT E JR · CIK 0001200847 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 168,719 F1 · shares: The original Form 4, filed on March 11, 2021, is being amended by this form 4 amendment solely to correct a typo in the amount of securities sold the original Form 4 read "5,926", whereas "3,755" was the correct amount. F1 · balance_after: The original Form 4, filed on March 11, 2021, is being amended by this form 4 amendment solely to correct a typo in the amount of securities sold the original Form 4 read "5,926", whereas "3,755" was the correct amount. Read SEC document |
| March 09, 2021 Filed Mar 10, 2021 00:57 UTC | INNOVATIVE SOLUTIONS & SUPPORT INC ISSC · Entity 544 | SaleCommon Stock | 5,000 | $6.20 | $31,000.00 |
DisclosureSEC source: 0001104659-21-033990 · tm217565-7_4seq1.xml · nonDerivative · entry 2 MITTELSTAEDT ROBERT E JR · CIK 0001200847 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 172,474 Read SEC document |
| March 08, 2021 Filed Mar 10, 2021 00:57 UTC | INNOVATIVE SOLUTIONS & SUPPORT INC ISSC · Entity 544 | SaleCommon Stock | 5,926 | $6.20 | $36,741.20 |
DisclosureSEC source: 0001104659-21-033990 · tm217565-7_4seq1.xml · nonDerivative · entry 1 MITTELSTAEDT ROBERT E JR · CIK 0001200847 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 177,474 Read SEC document |
| March 04, 2021 Filed Mar 6, 2021 00:14 UTC | INNOVATIVE SOLUTIONS & SUPPORT INC ISSC · Entity 544 | SaleCommon Stock | 8,244 | $6.07 | $50,041.08 |
DisclosureSEC source: 0001104659-21-032866 · tm217565-6_4seq1.xml · nonDerivative · entry 1 MITTELSTAEDT ROBERT E JR · CIK 0001200847 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 183,400 Read SEC document |
| March 03, 2021 Filed Mar 4, 2021 21:47 UTC | INNOVATIVE SOLUTIONS & SUPPORT INC ISSC · Entity 544 | SaleCommon Stock | 3,039 | $6.31 | $19,176.09 |
DisclosureSEC source: 0001104659-21-032151 · tm217565-5_4seq1.xml · nonDerivative · entry 1 MITTELSTAEDT ROBERT E JR · CIK 0001200847 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 191,644 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.30 to $6.35, inclusive. The reporting person undertakes to provide to Innovative Solutions & Support Inc. ("ISSC"), any security holder of ISSC or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 02, 2021 Filed Mar 3, 2021 21:36 UTC | INNOVATIVE SOLUTIONS & SUPPORT INC ISSC · Entity 544 | SaleCommon Stock | 5,000 | $6.33 | $31,650.00 |
DisclosureSEC source: 0001104659-21-031502 · tm217565-4_4seq1.xml · nonDerivative · entry 1 MITTELSTAEDT ROBERT E JR · CIK 0001200847 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 194,683 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.31 and $6.50, inclusive. The reporting person undertakes to provide to Innovative Solutions & Support Inc. ("ISSC"), any security holder of ISSC or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 25, 2021 Filed Feb 26, 2021 22:34 UTC | INNOVATIVE SOLUTIONS & SUPPORT INC ISSC · Entity 544 | SaleCommon Stock | 10,000 | $6.54 | $65,400.00 |
DisclosureSEC source: 0001104659-21-029421 · tm217565-3_4seq1.xml · nonDerivative · entry 1 MITTELSTAEDT ROBERT E JR · CIK 0001200847 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 199,683 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.50 to $6.58, inclusive. The reporting person undertakes to provide to Innovative Solutions & Support Inc. ("ISSC"), any security holder of ISSC or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 21:32 UTC | INNOVATIVE SOLUTIONS & SUPPORT INC ISSC · Entity 544 | GrantCommon Stock | 6,872 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-001545 · tm211837-4_4seq1.xml · nonDerivative · entry 1 MITTELSTAEDT ROBERT E JR · CIK 0001200847 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 209,683 F1 · security: Stock based compensation for the year ended December 31, 2020. Read SEC document |
| June 09, 2020 Filed Jun 10, 2020 20:06 UTC | INNOVATIVE SOLUTIONS & SUPPORT INC ISSC · Entity 544 | SaleCommon Stock | 24,978 | $5.08 | $126,863.26 |
DisclosureSEC source: 0001104659-20-072008 · a4.xml · nonDerivative · entry 1 MITTELSTAEDT ROBERT E JR · CIK 0001200847 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 202,811 Read SEC document |
| January 02, 2020 Filed Jan 7, 2020 01:30 UTC | INNOVATIVE SOLUTIONS & SUPPORT INC ISSC · Entity 544 | GrantCommon Stock | 18,264 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-20-001721 · a4.xml · nonDerivative · entry 1 MITTELSTAEDT ROBERT E JR · CIK 0001200847 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 227,789 F1 · security: Stock based compensation for the year ended December 31, 2019. Read SEC document |
| August 14, 2019 Filed Aug 15, 2019 20:01 UTC | INNOVATIVE SOLUTIONS & SUPPORT INC ISSC · Entity 544 | SaleCommon Stock | 14,133 | $5.08 | $71,795.64 |
DisclosureSEC source: 0001104659-19-046143 · a4.xml · nonDerivative · entry 1 MITTELSTAEDT ROBERT E JR · CIK 0001200847 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 209,525 Read SEC document |
| May 09, 2019 Filed May 13, 2019 16:12 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | Exercise / conversionRestricted Stock Unit · Derivative | 306 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-018244 · form4.xml · derivative · entry 2 MITTELSTAEDT ROBERT E JR · CIK 0001200847 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 306 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F2 · derivative.exercise_date: The Restricted Stock Units vested fully on May 9, 2019. F2 · derivative.expiration_date: The Restricted Stock Units vested fully on May 9, 2019. Read SEC document |
| May 09, 2019 Filed May 13, 2019 16:12 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | Exercise / conversionCommon Stock | 306 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-018244 · form4.xml · nonDerivative · entry 1 MITTELSTAEDT ROBERT E JR · CIK 0001200847 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,515 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. Read SEC document |
| May 03, 2019 Filed May 7, 2019 15:00 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | Exercise / conversionNon-qualified Stock Options · Derivative | 3,700 | $0.00 Strike: $64.42 | $0.00 |
DisclosureSEC source: 0001127602-19-017528 · form4.xml · derivative · entry 3 MITTELSTAEDT ROBERT E JR · CIK 0001200847 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,700 shares Expires 2019-05-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Director stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2008 Stock Incentive Plan. F3 · derivative.exercise_date: The option vested in three equal installments beginning on May 6, 2010 and is now fully exercisable. Read SEC document |
| May 03, 2019 Filed May 7, 2019 15:00 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | SaleCommon Stock | 3,700 | $166.30 | $615,310.00 |
DisclosureSEC source: 0001127602-19-017528 · form4.xml · nonDerivative · entry 2 MITTELSTAEDT ROBERT E JR · CIK 0001200847 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,209 F1 · kind: Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934. Read SEC document |
| May 03, 2019 Filed May 7, 2019 15:00 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | Exercise / conversionCommon Stock | 3,700 | $64.42 | $238,354.00 |
DisclosureSEC source: 0001127602-19-017528 · form4.xml · nonDerivative · entry 1 MITTELSTAEDT ROBERT E JR · CIK 0001200847 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,909 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 21:25 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | GrantRestricted Stock Unit · Derivative | 306 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-006001 · form4.xml · derivative · entry 3 MITTELSTAEDT ROBERT E JR · CIK 0001200847 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 306 Underlying: Common Stock · 306 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F3 · derivative.exercise_date: The Restricted Stock Units vest fully on February 12, 2020. F3 · derivative.expiration_date: The Restricted Stock Units vest fully on February 12, 2020. F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 21:25 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | Exercise / conversionRestricted Stock Unit · Derivative | 1,038 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-006001 · form4.xml · derivative · entry 2 MITTELSTAEDT ROBERT E JR · CIK 0001200847 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,038 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F2 · derivative.exercise_date: The Restricted Stock Units vested fully on February 12, 2019. F2 · derivative.expiration_date: The Restricted Stock Units vested fully on February 12, 2019. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 21:25 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | Exercise / conversionCommon Stock | 1,038 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-006001 · form4.xml · nonDerivative · entry 1 MITTELSTAEDT ROBERT E JR · CIK 0001200847 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,209 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. Read SEC document |
| January 02, 2019 Filed Jan 4, 2019 20:59 UTC | INNOVATIVE SOLUTIONS & SUPPORT INC ISSC · Entity 544 | GrantCommon Stock | 13,377 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-000400 · edgar.xml · nonDerivative · entry 1 MITTELSTAEDT ROBERT E JR · CIK 0001200847 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 223,658 F1 · security: Stock based compensation for the year ended December 31, 2018. Read SEC document |
| February 12, 2018 Filed Feb 14, 2018 14:09 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | GrantRestricted Stock Unit · Derivative | 1,038 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-005644 · form4.xml · derivative · entry 1 MITTELSTAEDT ROBERT E JR · CIK 0001200847 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,038 Underlying: Common Stock · 1,038 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F2 · derivative.expiration_date: The Restricted Stock Units vest fully on February 12, 2019. F3 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 07, 2018 Filed Feb 9, 2018 20:52 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | Exercise / conversionRestricted Stock Unit · Derivative | 1,263 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-004893 · form4.xml · derivative · entry 2 MITTELSTAEDT ROBERT E JR · CIK 0001200847 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,263 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F2 · derivative.exercise_date: The Restricted Stock Units vested fully on February 7, 2018. F2 · derivative.expiration_date: The Restricted Stock Units vested fully on February 7, 2018. Read SEC document |
| February 07, 2018 Filed Feb 9, 2018 20:52 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | Exercise / conversionCommon Stock | 1,263 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-18-004893 · form4.xml · nonDerivative · entry 1 MITTELSTAEDT ROBERT E JR · CIK 0001200847 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,171 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. Read SEC document |
| January 02, 2018 Filed Jan 3, 2018 22:45 UTC | INNOVATIVE SOLUTIONS & SUPPORT INC ISSC · Entity 544 | GrantCommon Stock | 11,494 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-000381 · edgar.xml · nonDerivative · entry 1 MITTELSTAEDT ROBERT E JR · CIK 0001200847 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 210,281 F1 · security: Stock based compensation for the year ended December 31, 2017. Read SEC document |
| February 24, 2017 Filed Feb 27, 2017 19:40 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | Exercise / conversionNon-qualified Stock Options · Derivative | 5,300 | $0.00 Strike: $75.63 | $0.00 |
DisclosureSEC source: 0001127602-17-008540 · form4.xml · derivative · entry 7 MITTELSTAEDT ROBERT E JR · CIK 0001200847 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,300 shares Expires 2018-05-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Director stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2008 Stock Incentive Plan. F2 · derivative.exercise_date: The option vested in three equal annual installments beginning on the date reflected in this column and is now fully exercisable. Read SEC document |
| February 24, 2017 Filed Feb 27, 2017 19:40 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | SaleCommon Stock | 367 | $142.72 | $52,378.24 |
DisclosureSEC source: 0001127602-17-008540 · form4.xml · nonDerivative · entry 6 MITTELSTAEDT ROBERT E JR · CIK 0001200847 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,908 Read SEC document |
| February 24, 2017 Filed Feb 27, 2017 19:40 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | SaleCommon Stock | 100 | $142.70 | $14,270.00 |
DisclosureSEC source: 0001127602-17-008540 · form4.xml · nonDerivative · entry 5 MITTELSTAEDT ROBERT E JR · CIK 0001200847 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,275 Read SEC document |
| February 24, 2017 Filed Feb 27, 2017 19:40 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | SaleCommon Stock | 2,000 | $142.69 | $285,380.00 |
DisclosureSEC source: 0001127602-17-008540 · form4.xml · nonDerivative · entry 4 MITTELSTAEDT ROBERT E JR · CIK 0001200847 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,375 Read SEC document |
| February 24, 2017 Filed Feb 27, 2017 19:40 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | SaleCommon Stock | 2,633 | $142.69 | $375,693.29 |
DisclosureSEC source: 0001127602-17-008540 · form4.xml · nonDerivative · entry 3 MITTELSTAEDT ROBERT E JR · CIK 0001200847 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,375 Read SEC document |
| February 24, 2017 Filed Feb 27, 2017 19:40 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | SaleCommon Stock | 200 | $142.68 | $28,536.00 |
DisclosureSEC source: 0001127602-17-008540 · form4.xml · nonDerivative · entry 2 MITTELSTAEDT ROBERT E JR · CIK 0001200847 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,008 Read SEC document |
| February 24, 2017 Filed Feb 27, 2017 19:40 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | Exercise / conversionCommon Stock | 5,300 | $75.63 | $400,839.00 |
DisclosureSEC source: 0001127602-17-008540 · form4.xml · nonDerivative · entry 1 MITTELSTAEDT ROBERT E JR · CIK 0001200847 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,208 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 09, 2017 Filed Feb 13, 2017 18:46 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | Exercise / conversionRestricted Stock Unit · Derivative | 1,560 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-005282 · form4.xml · derivative · entry 2 MITTELSTAEDT ROBERT E JR · CIK 0001200847 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,263 Underlying: Common Stock · 1,560 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F2 · derivative.exercise_date: The Restricted Stock Units vested fully on February 9, 2017. F2 · derivative.expiration_date: The Restricted Stock Units vested fully on February 9, 2017. F3 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 09, 2017 Filed Feb 13, 2017 18:46 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | Exercise / conversionCommon Stock | 1,560 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-17-005282 · form4.xml · nonDerivative · entry 1 MITTELSTAEDT ROBERT E JR · CIK 0001200847 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,908 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. Read SEC document |
| February 07, 2017 Filed Feb 9, 2017 19:24 UTC | LABCORP HOLDINGS INC. LH · Entity 1277 | GrantRestricted Stock Unit · Derivative | 1,263 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-004720 · form4.xml · derivative · entry 1 MITTELSTAEDT ROBERT E JR · CIK 0001200847 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,823 Underlying: Common Stock · 1,263 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F2 · derivative.expiration_date: The Restricted Stock Units vest fully on February 7, 2018. F3 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| January 02, 2017 Filed Jan 3, 2017 21:19 UTC | INNOVATIVE SOLUTIONS & SUPPORT INC ISSC · Entity 544 | Exercise / conversionRestricted Stock Units · Derivative | 14,234 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-000061 · edgar.xml · derivative · entry 2 MITTELSTAEDT ROBERT E JR · CIK 0001200847 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 14,234 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represented a contingent right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: The restricted stock units were granted on November 12, 2015 as compensation for service on the Issuer's board of directors during the year ended December 31, 2016 and vested in full on January 2, 2017. F2 · derivative.expiration_date: The restricted stock units were granted on November 12, 2015 as compensation for service on the Issuer's board of directors during the year ended December 31, 2016 and vested in full on January 2, 2017. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.